Earnings History Data for BioCardia, Inc. (BCDA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

BioCardia, Inc.

BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-03-2024	AH		BCDA	BioCardia, Inc.	8.76	-0.09	-0.11	-0.16	BioCardia GAAP EPS of -$0.55 misses by $0.09, revenue of $0.5M misses by $0.2M [3/27/2024 4:17 PM]	0.4137	-0.01 (-1.29%)	0.38	-0.04 (-8.61%)	0.36 - 2.92	216,480	180,000	64,278
BioCardia GAAP EPS of -$0.55 misses by $0.09, revenue of $0.5M misses by $0.2M [3/27/2024 4:17 PM]
08-11-2023	AH		BCDA	BioCardia, Inc.	8.76	-0.12	-0.12	-0.17	BioCardia GAAP EPS of -$0.12 [11/8/2023 4:51 PM]	0.41	-0.02 (-5.75%)	0.40	-0.04 (-8.05%)	0.36 - 2.92	67,607	40,000	361
BioCardia GAAP EPS of -$0.12 [11/8/2023 4:51 PM]
09-08-2023	AH		BCDA	BioCardia, Inc.	18.40	-0.17	-0.15	-0.14	BioCardia GAAP EPS of -$0.17, revenue of $43M [8/9/2023 4:22 PM]	0.88	-0.03 (-3.15%)	0.86	-0.05 (-5.34%)	0.85 - 2.92	28,280	150,000	212
BioCardia GAAP EPS of -$0.17, revenue of $43M [8/9/2023 4:22 PM]
10-05-2023	AH	4:05 PM ET (May 10)	BCDA	BioCardia, Inc.	41.17	-0.17	-0.13	-0.19	BioCardia GAAP EPS of -$0.17 in-line [5/10/2023 4:24 PM]	2.00	0.01 (0.50%)	0.0	0.0 (0.00%)	1.10 - 2.60	21,313	20,000	0
BioCardia GAAP EPS of -$0.17 in-line [5/10/2023 4:24 PM]
09-11-2022	AH	4:05 PM ET (Nov 9)	BCDA	BioCardia, Inc.	33.21	-0.17	-0.23	-0.16	BioCardia GAAP EPS of -$0.17, revenue of $0.21M [11/9/2022 4:28 PM]	1.88	-0.04 (-2.00%)	1.85	-0.07 (-3.57%)	1.10 - 2.85	27,317	20,000	1,550
BioCardia GAAP EPS of -$0.17, revenue of $0.21M [11/9/2022 4:28 PM] BioCardia, Inc. (BCDA) Reports Q3 Loss, Tops Revenue Estimates [Nov-09-22 05:35PM] BioCardia Reports Third Quarter 2022 Business Highlights and Financial Results [Nov-09-22 04:05PM] BioCardia, Inc. (BCDA) Upgraded to Buy: Here's What You Should Know [Nov-09-22 12:00PM]
10-08-2022	AH	4:15 PM ET (Aug 10)	BCDA	BioCardia, Inc.	27.22	-0.14	-0.28	-0.20		1.58	0.08 (5.07%)	1.50	0.0 (0.00%)	1.10 - 3.96	46,015	40,000	169
BioCardia Q2 GAAP loss per share narrows, revenue up [8/10/2022 4:49 PM] BioCardia Reports Second Quarter 2022 Business Highlights And Financial Results [Aug-10-22 04:05PM] BioCardia, Inc. (BCDA) Reports Q2 Loss, Tops Revenue Estimates [Aug-10-22 05:15PM]
11-05-2022	AH	4:05 PM ET (May 11)	BCDA	BioCardia, Inc.	22.68	-0.19	-0.15	-0.18	BioCardia GAAP EPS of -$0.19, revenue of $0.06M [5/11/2022 4:21 PM]	1.33	0.15 (12.71%)	1.11	-0.07 (-5.93%)	1.10 - 5.10	149,516	110,000	711
BioCardia GAAP EPS of -$0.19, revenue of $0.06M [5/11/2022 4:21 PM] BioCardia Reports First Quarter 2022 Business Highlights and Financial Results [May-11-22 04:15PM] BioCardia, Inc. (BCDA) Reports Q1 Loss, Lags Revenue Estimates [May-11-22 05:55PM]
29-03-2022	AH	4:30 PM ET (Mar 29)	BCDA	BioCardia, Inc.	36.10	-0.21	-0.21	-0.16	BioCardia GAAP EPS of -$0.75, revenue of $1M [3/29/2022 4:21 PM]	2.07	-0.05 (-2.36%)	2.12	0.0 (0.00%)	1.25 - 5.10	87,895	80,000	7,669
BioCardia GAAP EPS of -$0.75, revenue of $1M [3/29/2022 4:21 PM] BioCardia Reports 2021 Financial Results and Recent Business Highlights [Mar-29-22 04:05PM] Here's Why We're Watching BioCardia's (NASDAQ:BCDA) Cash Burn Situation [Mar-30-22 03:51PM]
10-11-2021	AH	After the close (Nov 10)	BCDA	BioCardia, Inc.	47.75	-0.16	-0.28	-0.30	BioCardia reports Q3 results [11/10/2021 5:14 PM]	2.55	-0.06 (-2.12%)	2.75	-0.02 (-0.72%)	2.00 - 8.60	33,519	30,000	101
BioCardia reports Q3 results [11/10/2021 5:14 PM] BioCardia To Release Third Quarter 2021 Financial Results November 10, 2021 [Nov-08-21 04:30PM] BioCardia Reports Third Quarter 2021 Financial Results and Business Highlights [Nov-10-21 04:30PM]
13-05-2021	PM	8:00 AM ET (May 13)	BCDA	Biocardia, Inc.	57.00	-0.18	-0.21	0.00	BioCardia reports Q1 results [5/13/2021 9:08 AM]	3.37	0.07 (2.12%)	0.0	0.0 (0.00%)	1.91 - 8.60	64,868	50,000	0
BioCardia reports Q1 results [5/13/2021 9:08 AM] BioCardia Reports First Quarter 2021 Financial Results and Business Highlights [May-13-21 08:00AM] BioCardia, Inc. (BCDA) Reports Q1 Loss, Tops Revenue Estimates [May-13-21 12:11PM]
10-11-2020	PM		BCDA	Biocardia, Inc.	24.00	-0.30	-0.28	0.00	BioCardia EPS misses by $0.01, beats on revenue [11/10/2020 7:22 AM]	2.05	0.13 (6.77%)	0.0	0.0 (0.00%)	1.91 - 6.75	41,068	57,087	0

15-05-2020	PM		BCDA	BioCardia, Inc.	28.01	-0.67	-0.32	-0.08	BioCardia EPS misses by $0.17 [5/15/2020 8:15 AM]	4.37	0.27 (6.59%)	0.0	0.0 (0.00%)	2.10 - 17.50	4,101	18,345	0